רגולציה ולגלזציה

The U.S. House of Representatives has approved a spending bill that would continue protecting state medical marijuana programs from federal intervention—while excluding a provision that previously advanced to block the Justice Department from rescheduling cannabis. Following bicameral negotiations on the appropriations package, the House advanced it in a 397-28 vote on Thursday, sending it to…

Cannabidiol (CBD), a non-intoxicating compound in marijuana, “holds substantial promise as an anti-tumor agent” in addition to its other anti-inflammatory properties, a new scientific review Scientists explored CBD’s effect on many types of cancer—including some of the most aggressive ones, such as glioblastoma, which affects the brain. They also noted it can help suppressing the…

If federal officials follow through on President Donald Trump’s recent executive order directing the reclassification of marijuana, it could free up Washington, D.C. to finally legalize recreational cannabis sales after a years-long congressional blockade. Moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) would not federally legalize marijuana, but it…

Retailers sold more than $836 million in recreational cannabis products last year, while medical marijuana sales exceeded $233 million. By Megan Henry, Ohio Capital Journal Ohio’s recreational marijuana sales surpassed more than $836 million in 2025, the first full year recreational sales were legal. Recreational sales started in August 2024 and the state’s total recreational…